1 |
Varma, T. K., T. E. Toliver-Kinsky, C. Y. Lin, A. P. Koutrouvelis, J. E. Nichols and E. R. Sherwood. 2001. Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice. Infec. Immun. 69, 5249-5263.
DOI
ScienceOn
|
2 |
Tsujimoto, M., Y. K. Yip and J. Vilcek. 1986. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor. J. Immunol. 136, 2441-2444.
|
3 |
Tracey, K. J. and A. Cerami. 1993. Tumor necrosis factor: an updated review of its biology. Crit. Care Med. 21, S415-422
|
4 |
Wright, B. E. and M. West. 2002. Pathophysiology of sepsis, pp. 53-62, In Windsor, A. (ed.), Sepsis and Multiple Organ Dysfuction: a Multidisciplinary Approach, WB Saunders, New York.
|
5 |
Yoza, B., K. LaRue and C. McCall. 1998. Molecular mechanisms responsible for endotoxin tolerance. Prog. Clin. Biol. Res. 397, 209-215.
|
6 |
Zuckerman, S. H. and G. F. Evans. 1992. Endotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell Immunol. 140, 513-519.
DOI
ScienceOn
|
7 |
Munford, R. A. and J. Pugin. 2001. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Infect. Immun. 69, 5249-5263.
DOI
|
8 |
Randow, F., U. Syrbe, C. Meisel, D. Krausch, H. Zuckermann, C. Platzer and H. D. Volk. 1995. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J. Exp. Med. 181, 1887-1892.
DOI
|
9 |
Randow, F., W. D. Docke, D. S. Bundschuh, T. Hartung, A. Wendel and H. D. Volk. 1997. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor. J. Immunol. 158, 2911-2918.
|
10 |
Soszynski, D. 2002. Inhibition of nitric oxide synthase delays the development of tolerance to LPS in rats. Physiol. Behav. 76, 159-169.
DOI
ScienceOn
|
11 |
Sanchez-Cantu, L., H. N. Rode and N. V. Christou. 1989. Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch. Surg. 124, 1432-1436
DOI
ScienceOn
|
12 |
Kang, M. K., Y. E.Yoon, J. Y. Yang, K. B. Kwon, J. W. Park and E. C. Jhee. 2004. Protective effect of retinoic acid on interleukin-1-induced cytotoxicity of pancreatic -cells. Mecha. Age. Develop. 125, 483-490.
DOI
ScienceOn
|
13 |
Heagy, W., C. Hansen, K. Nieman, L. Jorge and J. Rodriguez. 2000. Impaired mitogen-activated protein kinase activation and altered cytokine secretion in endotoxin-tolerant human monocytes. J. Trauma. 49, 1-8.
DOI
ScienceOn
|
14 |
Hewett, J. A. and R. A. Roth. 1993. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol. Rev. 45, 382-411.
|
15 |
Le, J., J. X. Lin, D. Henriksen-DeStefano and J. Vilcek. 1986. Bacterial lipopolysaccharide-induced interferon-gamma production: roles of interleukin-1 and interleukin-2. J.Immunol. 136, 4525-4530.
|
16 |
Koerner, T. J., D. O. Adams and T. A. Hamilton. 1987. Regulation of tumor necrosis factor (TNF) expression: interferon-gamma enhances the accumulation of mRNA for TNF induced by lipopolysaccharide in murine peritoneal macrophages. Cell Immunol. 109, 437-443.
DOI
ScienceOn
|
17 |
Kim, Y. M. and K. Son. 1996. A nitric oxide production bioassay for interferon-gamma. J. Immunol. Methods 198, 203-209.
DOI
ScienceOn
|
18 |
Marumo, T., T. Nakaki, H. Adachi, H. Esumi, H. Suzuki, T. Saruta and R. Kato. 1993. Nitric oxide synthase mRNA in endothelial cells: synergistic induction by interferongamma, tumor necrosis factor-alpha and lipopolysaccharide and inhibition by dexamethasone. Jpn. J. Pharmacol. 63, 327-334.
DOI
|
19 |
Moncada, S., R. M. Palmer and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142.
|
20 |
Mishell, B. B. and S. M. Shiigi. 1989. Preparation of mouse cell suspensions in selected methods in cellular immunology, pp. 3-27, In Mishell, B. B. and S. M. Shiigi (eds.), W.H. Freeman and company press, San Francisco.
|
21 |
Farrar, M. A. and R. D. Schreiber. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11, 571-611.
DOI
ScienceOn
|
22 |
Abbas, A. K., A. H. Lichtman and J. S. Pober. 1997. Cellular and Molecular Immunology. W.B. Saunders Co., Philadelphia.
|
23 |
Medvedev, V., P. Henneke, A. Schromm, E. Lien, R. Ingalls, M. Fenton, D. Golenbock and S. Vogel. 2000. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by over expression of Toll-like receptors 2 or 4. J. Immunol. 167, 2257-2267.
|
24 |
Parker, M. M. 1998. Pathophysiology of cardiovascular dysfunction in septic shock. New Horiz. 6, 130-138.
|
25 |
Ertel, W., J. P. Kremer, K. Kenney, U. Steckholzer, D. Jarrar, O. Trentz and F. W. Schildberg. 1995. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85, 1341-1347.
|
26 |
Bundschuh, D. S., J. Barsig, T. Hartung, F. Randow, W. D. Docke, H. D. Volk and A. Wendel. 1997. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. J. Immunol. 158, 2862-2871.
|
27 |
Freudenberg, M. A. and C. Galanos. 1988. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect. Immun. 56, 1352-1357.
|
28 |
Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126, 131-138.
DOI
ScienceOn
|
29 |
Henricson, B. E., C. L. Manthey, P. Y. Perera, T. A. Hamilton and S. N. Vogel. 1993. Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect. Immun. 61, 2325-2333.
|
30 |
Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101, 1644-1655.
DOI
ScienceOn
|
31 |
Li, S. P., S. I. Lee and J. E. Domer. 1998. Alterations in frequency of interleukin-2 (IL-2)-, gamma interferon-, or IL-4-secreting splenocytes induced by Candida albicans mannan and/or monophosphoryl lipid A. Infect. Immun. 66, 1392-1399.
|
32 |
Ross, M. E. and M. A. Caligiuri. 1997. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 89, 910-918.
|
33 |
Vincent, J. L., H. Zhang, C. Szabo' and J. C. Preiser. 2000. Effects of nitric oxide in septic shock. Am. J. Respir. Crit. Care Med. 161, 1781-1785.
DOI
ScienceOn
|